282 related articles for article (PubMed ID: 9869174)
1. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
[TBL] [Abstract][Full Text] [Related]
2. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels.
Vischer UM; Ingerslev J; Wollheim CB; Mestries JC; Tsakiris DA; Haefeli WE; Kruithof EK
Thromb Haemost; 1997 Feb; 77(2):387-93. PubMed ID: 9157601
[TBL] [Abstract][Full Text] [Related]
3. von Willebrand factor and its propeptide in children with diabetes. Relation between endothelial dysfunction and microalbuminuria.
Verrotti A; Greco R; Basciani F; Morgese G; Chiarelli F
Pediatr Res; 2003 Mar; 53(3):382-6. PubMed ID: 12595584
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous nature of microalbuminuria in NIDDM: studies of endothelial function and renal structure.
Fioretto P; Stehouwer CD; Mauer M; Chiesura-Corona M; Brocco E; Carraro A; Bortoloso E; van Hinsbergh VW; Crepaldi G; Nosadini R
Diabetologia; 1998 Feb; 41(2):233-6. PubMed ID: 9498659
[TBL] [Abstract][Full Text] [Related]
5. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
[TBL] [Abstract][Full Text] [Related]
6. Von Willebrand factor in diabetic angiopathy.
Kessler L; Wiesel ML; Attali P; Mossard JM; Cazenave JP; Pinget M
Diabetes Metab; 1998 Sep; 24(4):327-36. PubMed ID: 9805643
[TBL] [Abstract][Full Text] [Related]
7. Comparison between von Willebrand factor (VWF) and VWF antigen II in normal individuals and patients with von Willebrand disease.
de Romeuf C; Mazurier C
Thromb Haemost; 1998 Jul; 80(1):37-41. PubMed ID: 9684782
[TBL] [Abstract][Full Text] [Related]
8. Von Willebrand factor propeptide in vascular disorders.
van Mourik JA; Romani de Wit T
Thromb Haemost; 2001 Jul; 86(1):164-71. PubMed ID: 11487004
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification.
Chan NN; Fuller JH; Rubens M; Colhoun HM
Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of von Willebrand factor and its propeptide in plasma in acquired von Willebrand syndrome.
van Genderen PJ; Boertjes RC; van Mourik JA
Thromb Haemost; 1998 Sep; 80(3):495-8. PubMed ID: 9759633
[TBL] [Abstract][Full Text] [Related]
11. von Willebrand factor propeptide in malaria: evidence of acute endothelial cell activation.
Hollestelle MJ; Donkor C; Mantey EA; Chakravorty SJ; Craig A; Akoto AO; O'Donnell J; van Mourik JA; Bunn J
Br J Haematol; 2006 Jun; 133(5):562-9. PubMed ID: 16681646
[TBL] [Abstract][Full Text] [Related]
12. Biochemical markers of endothelial activation in primary hyperparathyroidism.
Fallo F; Cella G; Casonato A; Ermani M; Vettor R; Zanella S; Lumachi F
Horm Metab Res; 2006 Feb; 38(2):125-9. PubMed ID: 16523414
[TBL] [Abstract][Full Text] [Related]
13. Diabetes is associated with a high incidence of endothelial-binding antibodies which do not correlate with retinopathy, von Willebrand factor, angiotensin-converting enzyme or C-reactive protein.
Petty RG; Pottinger BE; Greenwood RM; Pearson JD; Mahler RF
Diabetes Res; 1991 Jul; 17(3):115-23. PubMed ID: 1668655
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.
Knudsen ST; Jeppesen P; Frederiksen CA; Andersen NH; Bek T; Ingerslev J; Mogensen CE; Poulsen PL
Diabet Med; 2007 Aug; 24(8):911-5. PubMed ID: 17559428
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasma soluble P-selectin and von Willebrand factor as indices of platelet activation and endothelial damage/dysfunction in high-risk patients with hypertension: a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial.
Varughese GI; Patel JV; Tomson J; Blann AD; Hughes EA; Lip GY
J Intern Med; 2007 Apr; 261(4):384-91. PubMed ID: 17391113
[TBL] [Abstract][Full Text] [Related]
16. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.
Zareba W; Pancio G; Moss AJ; Kalaria VG; Marder VJ; Weiss HJ; Watelet LF; Sparks CE
Thromb Haemost; 2001 Sep; 86(3):791-9. PubMed ID: 11583309
[TBL] [Abstract][Full Text] [Related]
17. Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus.
Ibrahim HA; El-Meligi AA; Abdel-Hamid M; Elhendy A
Med Sci Monit; 2004 Mar; 10(3):CR85-9. PubMed ID: 14976459
[TBL] [Abstract][Full Text] [Related]
18. Decrease in von Willebrand factor levels after a high-monounsaturated-fat diet in non-insulin-dependent diabetic subjects.
Rasmussen O; Thomsen C; Ingerslev J; Hermansen K
Metabolism; 1994 Nov; 43(11):1406-9. PubMed ID: 7526126
[TBL] [Abstract][Full Text] [Related]
19. Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial.
De Jager J; Kooy A; Lehert P; Bets D; Wulffelé MG; Teerlink T; Scheffer PG; Schalkwijk CG; Donker AJ; Stehouwer CD
J Intern Med; 2005 Jan; 257(1):100-9. PubMed ID: 15606381
[TBL] [Abstract][Full Text] [Related]
20. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
Lip PL; Belgore F; Blann AD; Hope-Ross MW; Gibson JM; Lip GY
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
